Get started
Author

Herbert Pfeiffer

Amitriptyline or Not, That Is the Question: Pharmacogenetic Testing of CYP2D6 and CYP2C19 Identifies Patients with Low or High Risk for Side Effects in Amitriptyline Therapy
2005 · Werner Steimer, Konstanze Zöpf, et al. · Clinical Chemistry · 178
Defining and predicting functional outcome in schizophrenia and schizophrenia spectrum disorders
2009 · Rebecca Schennach-Wolff, Markus Jäger, et al. · Schizophrenia Research · 119
Predictors of Relapse in the Year After Hospital Discharge Among Patients With Schizophrenia
2012 · Rebecca Schennach, Michael Obermeier, et al. · Psychiatric Services · 103
Patients’ and Psychiatrists’ Perceptions of Clinical Decisions During Schizophrenia Treatment
2008 · Johannes Hamann, Rosmarie T. Mendel, et al. · The Journal of Nervous and Mental Disease · 69
Psychopathological characteristics and treatment response of first episode compared with multiple episode schizophrenic disorders
2006 · Markus Jäger, Michael Riedel, et al. · European Archives of Psychiatry and Clinical Neuroscience · 69
PDF
Evaluating depressive symptoms and their impact on outcome in schizophrenia applying the Calgary Depression Scale
2010 · R. Schennach-Wolff, M. Obermeier, et al. · Acta Psychiatrica Scandinavica · 57
Evaluating Depressive Symptoms in Schizophrenia: A Psychometric Comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale
2012 · Rebecca Schennach, Michael Obermeier, et al. · Psychopathology · 54
PDF
Early improvement as a predictor of remission and response in schizophrenia: Results from a naturalistic study
2009 · M. Jäger, M. Schmauß, et al. · European Psychiatry · 45
One-year functional outcomes of naturalistically treated patients with schizophrenia
2012 · Ilja Spellmann, Michael Riedel, et al. · Psychiatry Research · 43
What are residual symptoms in schizophrenia spectrum disorder? Clinical description and 1-year persistence within a naturalistic trial
2014 · Rebecca Schennach, Michael Riedel, et al. · European Archives of Psychiatry and Clinical Neuroscience · 42
Quality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders: Valid predictors of symptomatic response and remission?
2010 · Rebecca Schennach-Wolff, Markus Jäger, et al. · The World Journal of Biological Psychiatry · 39
Insight in schizophrenia–course and predictors during the acute treatment phase of patients suffering from a schizophrenia spectrum disorder
2012 · R. Schennach, S. Meyer, et al. · European Psychiatry · 33
Response trajectories in “real-world” naturalistically treated schizophrenia patients
2012 · Rebecca Schennach, Sebastian Meyer, et al. · Schizophrenia Research · 32
Attitude towards adherence in patients with schizophrenia at discharge
2009 · Rebecca Schennach-Wolff, Markus Jäger, et al. · Journal of Psychiatric Research · 28
Does Clinical Judgment of Baseline Severity and Changes in Psychopathology Depend on the Patient Population?
2010 · Rebecca Schennach-Wolff, Michael Obermeier, et al. · Journal of Clinical Psychopharmacology · 27
Prediction of symptom remission in schizophrenia during inpatient treatment
2008 · Markus Jäger, Michael Riedel, et al. · The World Journal of Biological Psychiatry · 27
Outcome of suicidal patients with schizophrenia: results from a naturalistic study
2009 · R. Schennach‐Wolff, M. Jäger, et al. · Acta Psychiatrica Scandinavica · 26
Depression during an acute episode of schizophrenia or schizophreniform disorder and its impact on treatment response
2008 · Markus Jäger, Michael Riedel, et al. · Psychiatry Research · 24
What are depressive symptoms in acutely ill patients with schizophrenia spectrum disorder?
2014 · R. Schennach, M. Riedel, et al. · European Psychiatry · 23
Influencing factors and predictors of early improvement in the acute treatment of schizophrenia and schizophrenia spectrum disorder
2011 · Rebecca Schennach-Wolff, Sebastian Meyer, et al. · Journal of Psychiatric Research · 23
Remission and Recovery and their Predictors in Schizophrenia Spectrum Disorder: Results from a 1-Year Follow-Up Naturalistic Trial
2011 · Rebecca Schennach, Michael Riedel, et al. · Psychiatric Quarterly · 22
Standardized Remission Criteria in Schizophrenia: Descriptive Validity and Comparability with Previously Used Outcome Measures
2008 · M. Jäger, T. Messer, et al. · Pharmacopsychiatry · 21
Time course of antipsychotic treatment response in schizophrenia: Results from a naturalistic study in 280 patients
2010 · M. Jäger, M. Riedel, et al. · Schizophrenia Research · 18
Response and remission of subjective well-being in patients suffering from schizophrenia spectrum disorders
2010 · R. Schennach-Wolff, F. Seemüller, et al. · European Psychiatry · 15
Remission in schizophrenia — What are we measuring? Comparing the consensus remission criteria to a CGI-based definition of remission and to remission in major depression
2019 · Rebecca Schennach, Michael Obermeier, et al. · Schizophrenia Research · 12
Works count: 44
Citation count: 1,222
H-index: 21
I10-index: 29
Year
Topic
Type